These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits. Gibson GE; Pelmas CJ; Peterson C Pharmacol Biochem Behav; 1983 Jun; 18(6):909-16. PubMed ID: 6136988 [TBL] [Abstract][Full Text] [Related]
7. Effects of phencyclidine, atropine and physostigmine, alone and in combination, on variable-interval performance in the squirrel monkey. Chait LD; Balster RL Pharmacol Biochem Behav; 1979 Jul; 11(1):37-42. PubMed ID: 115014 [TBL] [Abstract][Full Text] [Related]
8. Mecamylamine reverses physostigmine-induced attenuation of scopolamine-induced hyperactivity. O'Neill MF; Fernández AG; Gristwood RW; Palacios JM J Neural Transm Gen Sect; 1994; 96(1):9-18. PubMed ID: 7857593 [TBL] [Abstract][Full Text] [Related]
10. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia. Sienkiewicz-Jarosz H; Członkowska AI; Siemiatkowski M; Maciejak P; Szyndler J; Płaźnik A J Neural Transm (Vienna); 2000; 107(12):1403-12. PubMed ID: 11458993 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular responses to injections of cholinomimetic drugs into the cerebral ventricles of unanaesthetized dogs. Lang WJ; Rush ML Br J Pharmacol; 1973 Feb; 47(2):196-205. PubMed ID: 4722036 [TBL] [Abstract][Full Text] [Related]
12. Involvement of central cholinoceptors in Metrazol-induced convulsions. Rastogi SK; Puri JN; Sinha JN; Bhargava KP Psychopharmacology (Berl); 1979 Oct; 65(2):215-7. PubMed ID: 117491 [TBL] [Abstract][Full Text] [Related]
13. Methamphetamine, physostigmine, atropine and mecamylamine: effects on force lever performance. Preston KL; Schuster CR; Seiden LS Pharmacol Biochem Behav; 1985 Nov; 23(5):781-8. PubMed ID: 4080764 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin. Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910 [TBL] [Abstract][Full Text] [Related]
15. Role of the medial septum cholinoceptors in anxiogenic-like effects of nicotine. Zarrindast MR; Tajik R; Ebrahimi-Ghiri M; Nasehi M; Rezayof A Physiol Behav; 2013 Jul; 119():103-9. PubMed ID: 23769693 [TBL] [Abstract][Full Text] [Related]
16. Further evidence for nicotinic and muscarinic receptors and their interaction in dog adrenal medulla. Tsujimoto A; Nishikawa T Eur J Pharmacol; 1975 Dec; 34(2):337-44. PubMed ID: 1234552 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological evidence for nicotinic and muscarinic modulation of spinal cord reflexes. Ibrahim NA; Goldstein BD Neuropharmacology; 1989 Sep; 28(9):977-83. PubMed ID: 2812287 [TBL] [Abstract][Full Text] [Related]
18. Effects of chemoreceptor stimulating agents on reflex bradycardia. Matsumoto S; Nagao T; Ibi A; Nakajima T Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):296-307. PubMed ID: 39534 [TBL] [Abstract][Full Text] [Related]